DUBLIN--(BUSINESS WIRE)--The "Artificial Intelligence (AI) in Drug Discovery Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2027" report has been added to ResearchAndMarkets.com's offering.
The report predicts the global artificial intelligence (AI) in drug discovery market to grow with a CAGR of 30.2% over the forecast period from 2021-2027.
The report on the global artificial intelligence (AI) in drug discovery market provides qualitative and quantitative analysis for the period from 2019 to 2027. The study on artificial intelligence (AI) in drug discovery market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific, and RoW for the period of 2019 to 2027.
The report on artificial intelligence (AI) in drug discovery market is a comprehensive study and presentation of drivers, restraints, opportunities, demand factors, market size, forecasts, and trends in the global artificial intelligence (AI) in drug discovery market over the period of 2019 to 2027. Moreover, the report is a collective presentation of primary and secondary research findings.
Porter's five forces model in the report provides insights into the competitive rivalry, supplier and buyer positions in the market and opportunities for the new entrants in the global artificial intelligence (AI) in drug discovery market over the period of 2019 to 2027. Further, Growth Matrix gave in the report brings an insight into the investment areas that existing or new market players can consider.
Report Findings
1) Drivers
- Increasing use of artificial intelligence to efficiently study the drug activity
- Reduced costs of drug discovery
2) Restraints
- Low quality and inconsistent available data
3) Opportunities
- Generation of huge amount of data
Company Profiles
- GNS Healthcare
- BenevolentAI Limited
- Atomwise Inc.
- Cyclica Inc.
- Deep Genomics
- Exscientia plc
- IBM Corporation
- Alphabet Inc.
- NVIDIA Corporation
- Microsoft Corporation
Key Topics Covered:
1. Preface
1.1. Report Description
1.2. Research Methods
1.3. Research Approaches
2. Executive Summary
2.1. Artificial Intelligence (AI) in Drug Discovery Market Highlights
2.2. Artificial Intelligence (AI) in Drug Discovery Market Projection
2.3. Artificial Intelligence (AI) in Drug Discovery Market Regional Highlights
3. Global Artificial Intelligence (AI) in Drug Discovery Market Overview
3.1. Introduction
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
3.3. Analysis of COVID-19 impact on the Artificial Intelligence (AI) in Drug Discovery Market
3.4. Porter's Five Forces Analysis
3.5. Growth Matrix Analysis
3.6. Value Chain Analysis of Artificial Intelligence (AI) in Drug Discovery Market
4. Artificial Intelligence (AI) in Drug Discovery Market Macro Indicator Analysis
5. Global Artificial Intelligence (AI) in Drug Discovery Market by Offering
5.1. Software
5.2. Services
6. Global Artificial Intelligence (AI) in Drug Discovery Market by Technology
6.1. Machine Learning
6.2. Natural Language Processing (NLP)
6.3. Computer Vision
6.4. Others
7. Global Artificial Intelligence (AI) in Drug Discovery Market by Application
7.1. Target Identification
7.2. Molecule Screening
7.3. Drug Design and Drug Optimization
7.4. Preclinical and Clinical Testing
7.5. Others
8. Global Artificial Intelligence (AI) in Drug Discovery Market by Indication
8.1. Oncology
8.2. Neurodegenerative Diseases
8.3. Infectious Disease
8.4. Others
9. Global Artificial Intelligence (AI) in Drug Discovery Market by End User
9.1. Pharmaceutical & BIoTechnology Companies
9.2. Contract Research Organizations
9.3. Academic & Government Research Institutes
10. Global Artificial Intelligence (AI) in Drug Discovery Market by Region 2021-2027
10.1. North America
10.1.1. North America Artificial Intelligence (AI) in Drug Discovery Market by Offering
10.1.2. North America Artificial Intelligence (AI) in Drug Discovery Market by Technology
10.1.3. North America Artificial Intelligence (AI) in Drug Discovery Market by Application
10.1.4. North America Artificial Intelligence (AI) in Drug Discovery Market by Indication
10.1.5. North America Artificial Intelligence (AI) in Drug Discovery Market by End User
10.1.6. North America Artificial Intelligence (AI) in Drug Discovery Market by Country
10.2. Europe
10.3. Asia-Pacific
10.4. RoW
11. Company Profiles and Competitive Landscape
11.1. Competitive Landscape in the Global Artificial Intelligence (AI) in Drug Discovery Market
11.2. Companies Profiles
- GNS Healthcare
- BenevolentAI Limited
- Atomwise Inc.
- Cyclica Inc.
- Deep Genomics
- Exscientia plc
- IBM Corporation
- Alphabet Inc.
- NVIDIA Corporation
- Microsoft Corporation
For more information about this report visit https://www.researchandmarkets.com/r/s67gr3
